Procaps Group S.A. (NASDAQ:PROC) Short Interest Up 56.5% in September

Procaps Group S.A. (NASDAQ:PROC) saw a large growth in short interest in September. As of September 15th, there was short interest totalling 18,000 shares, a growth of 56.5% from the August 31st total of 11,500 shares. Based on an average daily volume of 5,400 shares, the days-to-cover ratio is currently 3.3 days. Approximately 0.1% of the company’s stock are short sold.

Procaps Group Price Performance

PROC stock opened at $2.23 on Friday. The stock has a market capitalization of $251.59 million, a PE ratio of 4.29 and a beta of 0.15. The company’s 50-day moving average is $2.06 and its 200-day moving average is $2.49. Procaps Group has a 1 year low of $1.68 and a 1 year high of $4.95.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.